Evidence map›Paper›PMID 36499208›Full record

ArticleInternational journal of molecular sciences2022

RvD1

Maria G Balta, Olav Schreurs, Rashi Halder, Thomas M Küntziger, Frank Saetre, Inger Johanne S Blix, Espen S Baekkevold, Enrico Glaab, Karl Schenck

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Maria G BaltaInstitute of Oral Biology, University of Oslo, 0316 Oslo, Norway.ORCID 0000-0002-5831-1253
Olav SchreursInstitute of Oral Biology, University of Oslo, 0316 Oslo, Norway.ORCID 0000-0003-2536-9659
Rashi HalderLuxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 4367 Belvaux, Luxembourg.
Thomas M KüntzigerInstitute of Oral Biology, University of Oslo, 0316 Oslo, Norway.ORCID 0000-0003-3074-9509
Frank SaetreDepartment of Pathology, Oslo University Hospital, 0316 Oslo, Norway.
Inger Johanne S BlixInstitute of Oral Biology, University of Oslo, 0316 Oslo, Norway.
Espen S BaekkevoldInstitute of Oral Biology, University of Oslo, 0316 Oslo, Norway.
Enrico GlaabLuxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 4367 Belvaux, Luxembourg.ORCID 0000-0003-3977-7469
Karl SchenckInstitute of Oral Biology, University of Oslo, 0316 Oslo, Norway.ORCID 0000-0002-3021-4953
University of Oslo · NOOslo University Hospital · NOUniversity of Luxembourg · LU

Funding

Foundation for Dental Research UNIFOR (Stiftelsen til tannlegevitenskapens fremme, Oslo, Norway) 975 503 178/ 7729.
6 · The paper itself

Abstract

Specialized pro-resolving mediators (SPMs) are multifunctional lipid mediators that participate in the resolution of inflammation. We have recently described that oral epithelial cells (OECs) express receptors of the SPM resolvin RvD1

Indexed as

Transcription Factor RelATumor Necrosis Factor-alphaActive Transport, Cell NucleusEpithelial CellsHumansInflammationNF-kappa BNF-kappa BTranscription Factor RelATumor Necrosis Factor-alphagingivalNF-κBoral epitheliumoral inflammationp65periodontitisresolvinspecialized pro-resolving mediators

Identifiers

PMID36499208
PMCPMC9737907
OpenAlexW4310184921

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.